PL2244734T3 - Sposób indukcji tolerancji na alergen - Google Patents

Sposób indukcji tolerancji na alergen

Info

Publication number
PL2244734T3
PL2244734T3 PL09706855T PL09706855T PL2244734T3 PL 2244734 T3 PL2244734 T3 PL 2244734T3 PL 09706855 T PL09706855 T PL 09706855T PL 09706855 T PL09706855 T PL 09706855T PL 2244734 T3 PL2244734 T3 PL 2244734T3
Authority
PL
Poland
Prior art keywords
allergen
inducing tolerance
inducing
tolerance
Prior art date
Application number
PL09706855T
Other languages
English (en)
Inventor
Mimi Lai-Kuan Tang
Original Assignee
Murdoch Childrens Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40913317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2244734(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2008900463A external-priority patent/AU2008900463A0/en
Application filed by Murdoch Childrens Research Institute filed Critical Murdoch Childrens Research Institute
Publication of PL2244734T3 publication Critical patent/PL2244734T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588Adjuvants of undefined constitution
    • A61K2039/55594Adjuvants of undefined constitution from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL09706855T 2008-02-01 2009-01-30 Sposób indukcji tolerancji na alergen PL2244734T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2008900463A AU2008900463A0 (en) 2008-02-01 A method of inducing tolerance to an allergen

Publications (1)

Publication Number Publication Date
PL2244734T3 true PL2244734T3 (pl) 2017-01-31

Family

ID=40913317

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09706855T PL2244734T3 (pl) 2008-02-01 2009-01-30 Sposób indukcji tolerancji na alergen

Country Status (14)

Country Link
US (6) US9402896B2 (pl)
EP (2) EP2244734B1 (pl)
AU (1) AU2009208390B2 (pl)
CY (1) CY1117948T1 (pl)
DK (1) DK2244734T3 (pl)
ES (2) ES2950396T3 (pl)
HR (1) HRP20160945T1 (pl)
HU (1) HUE029000T2 (pl)
LT (1) LT2244734T (pl)
NZ (1) NZ587137A (pl)
PL (1) PL2244734T3 (pl)
PT (1) PT2244734T (pl)
SI (1) SI2244734T1 (pl)
WO (1) WO2009094717A2 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2244734T3 (pl) 2008-02-01 2017-01-31 Murdoch Childrens Research Institute Sposób indukcji tolerancji na alergen
MX2014009285A (es) * 2012-02-07 2015-02-04 Jolla Inst Allergy Immunolog Alergenos del fleo de los prados y metodos y usos para la modulacion de respuesta inmune.
DE102012101864A1 (de) * 2012-03-06 2013-09-12 Gramme-Revit Gmbh Mittel zur Behandlung von Allergien und anderen Erkrankungen
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
KR20170117562A (ko) 2015-02-20 2017-10-23 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 혼합 알레르겐 조성물 및 그의 사용 방법
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
WO2019018529A1 (en) 2017-07-18 2019-01-24 Before Brands, Inc. METHODS OF MAKING MIXED ALLERGEN COMPOSITIONS
ES2997871T3 (en) 2017-12-06 2025-02-18 Prollergy Corp Composition and method for reducing allergic response
US12433945B2 (en) * 2018-08-16 2025-10-07 Société des Produits Nestlé S.A. Peanut oral immunotherapy with maintenance dose
AU2020213085A1 (en) 2019-01-23 2021-08-12 Société des Produits Nestlé S.A. Methods for making mixed allergen compositions
CA3161935A1 (en) * 2019-12-23 2021-07-01 Mimi Lai-Kuan Tang Oral immunotherapy comprising peanut allergens
KR20220119076A (ko) * 2019-12-23 2022-08-26 프로타 테라퓨틱스 피티와이 엘티디 약학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
AUPQ415899A0 (en) 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases
AU1951001A (en) 2000-04-06 2001-09-17 Panacea Pharm Llc Microbial delivery system
US7060687B2 (en) * 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
JP2008523116A (ja) * 2004-12-14 2008-07-03 アルカベロ アクチェセルスカプ 異種タンパク質化合物をディスプレイするバクテリア細胞を含んでなる医薬組成物
US20060233772A1 (en) 2005-04-15 2006-10-19 Udo Herz Method for preventing or treating the development of respiratory allergies
EP1723965A1 (en) * 2005-05-18 2006-11-22 Stallergenes Sa Compositions for antigen-specific induction of immuno-tolerance via oral immunization
EP1814516B1 (en) * 2005-11-04 2012-12-26 Alk-Abelló A/S Use of a liquid allergy vaccine formulation for oromucosal administration
WO2007123488A1 (en) * 2006-04-20 2007-11-01 National University Of Singapore Recombinant lactobacillus and use of the same
PL2244734T3 (pl) 2008-02-01 2017-01-31 Murdoch Childrens Research Institute Sposób indukcji tolerancji na alergen

Also Published As

Publication number Publication date
EP3097927A1 (en) 2016-11-30
AU2009208390B2 (en) 2014-07-17
PT2244734T (pt) 2016-08-05
US20230107507A1 (en) 2023-04-06
DK2244734T3 (en) 2016-08-15
EP2244734A4 (en) 2012-05-23
US20200197515A1 (en) 2020-06-25
US20110097361A1 (en) 2011-04-28
HUE029000T2 (en) 2017-02-28
LT2244734T (lt) 2016-09-12
US10071157B2 (en) 2018-09-11
EP3097927B1 (en) 2023-05-03
US9402896B2 (en) 2016-08-02
US20250161439A1 (en) 2025-05-22
NZ587137A (en) 2013-02-22
AU2009208390A1 (en) 2009-08-06
US20160228542A1 (en) 2016-08-11
HRP20160945T1 (hr) 2016-11-04
EP2244734A2 (en) 2010-11-03
SI2244734T1 (sl) 2016-11-30
ES2585407T3 (es) 2016-10-05
WO2009094717A3 (en) 2010-10-21
ES2950396T3 (es) 2023-10-09
EP2244734B1 (en) 2016-05-04
CY1117948T1 (el) 2017-05-17
US20190070288A1 (en) 2019-03-07
WO2009094717A2 (en) 2009-08-06

Similar Documents

Publication Publication Date Title
PT2244734T (pt) Método para induzir tolerância a um alérgeno
GB0811942D0 (en) Method of designing a structure
GB2458745B (en) A method of forming an article
PL2376507T3 (pl) Sposób otrzymywania hydroksymetylofosfonianów
GB2470067B (en) Method of printing
AP3169A (en) A method of improved positioning
PL2376347T3 (pl) Sposób montażu łatwo otwieranego zakończenia puszki
PL2441166T3 (pl) Sposób i układ do eksploatacji turbozespołu w trybie obracania
GB0904571D0 (en) A method of manufacturing a component comprising an internal structure
TWI366236B (en) Method of forming power device
EP2256227A4 (en) METHOD FOR REPAIRING AN ELEMENT
GB0810532D0 (en) Method of making an oled
GB0921896D0 (en) A method of manufacturing a component
PL2440382T3 (pl) Sposób formowania elementu składowego
EP2255187A4 (en) METHOD FOR ASSESSING THE STABILITY OF PROTEINS
ZA201105114B (en) Method of manufacturing components
GB0905458D0 (en) Method of altering nucleic acids
PL385356A1 (pl) Sposób wytwarzania tadalafilu
GB0911416D0 (en) A method of forming an internal structure within a hollow component
GB2461497B (en) A method of forming an article
GB2489855B (en) A method of forming an article
EP2424539A4 (en) PROCESS FOR TREATING DEPRESSION
EP2404891A4 (en) PROCESS FOR THE PREPARATION OF ACYLBENZENES
GB0909660D0 (en) Method of altering nucleic acids
AU2008900463A0 (en) A method of inducing tolerance to an allergen